Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:MFIN
NasdaqGS:MFINConsumer Finance

Medallion Financial (MFIN): Profit Margin Decline Undermines Bullish Value Narratives Despite Low P/E

Medallion Financial (MFIN) closed the period with a net profit margin of 12.6%, down from last year's 15%, as the company reported negative earnings growth year over year. Despite this setback, over the past five years Medallion Financial has turned profitable, posting an average annual earnings growth rate of 28.3%. The stock is currently priced at $9.87, which trades well below its estimated fair value of $16.02. Its current Price-To-Earnings ratio of 5.3x stands out as notably lower than...
NYSE:STEM
NYSE:STEMElectrical

Can Stem (STEM) Narrowing Guidance Reveal More About Its Path to Sustainable Profitability?

Stem, Inc. recently reported third quarter 2025 earnings, showing revenue growth to US$38.24 million and a net loss of US$23.79 million, both improved compared to a year earlier; the company also updated its full-year revenue guidance to a range of US$135 million to US$160 million. Compared to last year, Stem recorded a significant improvement in its net income for the first nine months of 2025, turning a net loss into positive income, while narrowing its annual revenue guidance range to...
NasdaqGS:TREE
NasdaqGS:TREEConsumer Finance

LendingTree (TREE) Losses Deepen 28.9% Annually, Value Case Builds as Profitability Targeted

LendingTree (TREE) remains unprofitable, with losses having deepened at a rate of 28.9% per year over the past five years. While revenue is projected to grow by 5.3% per year, which is slower than the broader US market's 10.3% rate, earnings are forecast to improve by a robust 34.31% per year. Profitability is expected within the next three years. Investors are keeping a close eye on the company's progress toward profitability, as the focus shifts to anticipated earnings growth despite a...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

Laureate Education (LAUR) Margin Growth Reinforces Bullish Narratives Despite Slower Revenue Forecasts

Laureate Education (LAUR) posted another year of solid progress, with EPS climbing 26.6%. This growth is slower than its rapid 74.2% five-year average, but still marks consistent growth. Net profit margins advanced to 16.4% from 13% previously, reflecting greater operational efficiency and ongoing profitability. Investors will note these steady gains, as well as forecasts for ongoing earnings growth outpacing the broader US market, as key positives in the current report. See our full analysis...
NasdaqGS:AMSF
NasdaqGS:AMSFInsurance

AMERISAFE (AMSF) Margin Decline Reinforces Market Caution Despite Discounted Valuation

AMERISAFE (AMSF) posted a net profit margin of 16.5%, down from last year’s 18.5%, as earnings have declined by 12.6% annually over the past five years and are forecast to shrink a further 6.4% per year in the next three years. Revenue is expected to grow at just 4.8% per year, lagging the broader US market’s 10.3% pace, while the stock trades at $39.94, notably below the estimated fair value of $55.41. Despite these headwinds and concerns around dividend sustainability, management points to...
NYSE:DHT
NYSE:DHTOil and Gas

DHT Holdings (DHT): Margin Surge Reinforces Bullish Value Narrative Despite Dividend Concerns

DHT Holdings (NYSE:DHT) posted a net profit margin of 37.1%, increasing from 27.7% last year, with earnings accelerating to 23.6% annual growth, well above the five-year average of 8.5%. Revenue is forecast to grow at 6.4% per year while earnings are projected to rise 14.2% annually. Both figures trail the broader US market growth rates, and the stock currently trades at a Price-To-Earnings ratio of 10.5x, notably lower than industry peers and its estimated fair value. With sustained margin...
NasdaqGS:DRS
NasdaqGS:DRSAerospace & Defense

Leonardo DRS (DRS) Earnings Growth Surges 33.8%, Reinforcing Bullish Community Narrative

Leonardo DRS (DRS) delivered a standout 33.8% earnings growth over the last year, handily beating its 5-year average annual pace of 10.4%. Net profit margins rose to 7.4%, up from 6.2% last year, pointing to improved profitability. Looking ahead, the company expects earnings to increase 15.8% per year, with more modest revenue gains of 5.6% annually. This rate is slower than the US market’s 10.3% average. DRS trades at a Price-to-Earnings ratio of 36.2x, below the US Aerospace & Defense...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Indivior (INDV) One-Off $165M Loss Challenges Bullish Profit Growth Narratives

Indivior (NasdaqGS:INDV) reported a notable turnaround to profitability over the past year, with earnings now projected to grow at an impressive 26.6% per year through the next three years. This is well ahead of the US market’s 15.7% average earnings growth. Despite this strong outlook, revenue growth is expected to be much more modest at 2.9% annually, and a one-off $165 million loss in the latest twelve months to September 30, 2025, has had a significant impact on the most recent reported...
NasdaqCM:AMRN
NasdaqCM:AMRNBiotechs

Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes

Amarin (AMRN) remains unprofitable with losses accelerating at 30.6% per year over the past five years, while its net profit margin has shown no signs of improvement for the latest reported period. Looking ahead, analysts forecast earnings to grow sharply at 98.63% per year, with the company expected to achieve profitability within three years. This is despite revenue being projected to fall by 15.7% per year over that timeframe. Investors are parsing these results for signs that Amarin’s...
ASX:REH
ASX:REHTrade Distributors

Reece (ASX:REH) Valuation in Focus Following Leadership Changes and Boardroom Activism

Reece (ASX:REH) has announced two governance changes that could shape how investors view the company’s leadership. The company named Jacqueline Chow as an Independent Non-Executive Director and Chair of the Remuneration Committee. It also addressed investor activism ahead of its upcoming Annual General Meeting. See our latest analysis for Reece. Despite these high-profile governance changes and some investor activism leading up to the AGM, Reece’s momentum has been mixed. The share price has...
LSE:MGNS
LSE:MGNSConstruction

Top UK Dividend Stocks: Hargreaves Services Leads These 3 Picks

As the UK market grapples with global economic uncertainties, particularly the ripple effects of China's sluggish recovery and its impact on commodity prices, investors are increasingly turning their attention to dividend stocks as a source of stability. In such volatile times, stocks that offer reliable dividends can provide a cushion against market fluctuations while potentially delivering steady income streams.
NYSE:CMG
NYSE:CMGHospitality

Chipotle (CMG): Profit Margins Decline to 13% Challenges Outperformance Narrative

Chipotle Mexican Grill (CMG) posted earnings growth of 3.5% over the past year, a considerable slowdown from its five-year average of 27.4% per year. Profit margins edged down to 13%, compared to 13.5% a year earlier, while forecasts show earnings are expected to grow at 11.1% per year, which is slower than the broader US market’s 15.9% projection. For investors, the core reward is Chipotle’s track record of long-term outperformance and consistent revenue growth, though recent momentum has...
NYSE:EBS
NYSE:EBSBiotechs

Emergent BioSolutions (EBS): One-Off $42.1M Loss Clouds Return to Profit, Tests Bullish Narratives

Emergent BioSolutions (EBS) recently turned profitable, reversing a multi-year trend of losses. However, headline numbers were clouded by a hefty one-off charge of $42.1 million that weighed on reported earnings for the last twelve months. Long-term comparisons remain tough, as the company’s average annual earnings have declined by 40.2% over five years. Current forecasts point to a 53.8% annual drop in EPS and a 1.2% annual revenue dip over the next three years. Despite a price-to-earnings...
NasdaqGS:IART
NasdaqGS:IARTMedical Equipment

Integra LifeSciences (IART): Deep Valuation Discount Tests Profitability Timeline, Spotlights Risk-Reward Divide

Integra LifeSciences Holdings (IART) is currently unprofitable, with losses having widened over the past five years at a rate of 51.4% per year. Despite negative earnings and stagnant net profit margins in the most recent year, the company is projected to return to profitability within the next three years. This forecast is supported by a substantial expected earnings growth rate of 166.84% per year. In this context, investors are paying attention to IART’s discounted valuation relative to...
OB:NEL
OB:NELElectrical

Nel (OB:NEL): Revenue Forecast to Grow 14.9% Annually, Unprofitability Persists Ahead of Earnings

Nel (OB:NEL) remains unprofitable, with losses increasing at an annual rate of 17.3% over the last five years and no visible improvement in net profit margin. Revenue, however, is forecast to grow by 14.9% per year, significantly ahead of the Norwegian market's 2.8% pace. Shares have struggled for direction recently, with the stock price showing little stability over the past three months as investors weigh strong projected revenue growth against ongoing losses and a relatively high...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

MYR Group (MYRG) Profit Margin Rise Reinforces Bullish Narratives on Earnings Turnaround

MYR Group (MYRG) delivered a sharp turnaround in profitability with net profit margins rising to 2.8%, up from 1.1% a year prior, and annual earnings growth surging 155.1% compared to a 5-year average decline of 2.8% per year. Looking forward, analysts expect earnings for the company to increase at an annual rate of 14.6%, alongside 7.2% revenue growth per year. The current P/E ratio of 33.9x sits slightly below industry averages. These results highlight an encouraging improvement in margins...
BIT:CPR
BIT:CPRBeverage

Campari (BIT:CPR) Margin Miss Undercuts Bull Case as €185.7m One-Off Loss Weighs on Results

Davide Campari-Milano (BIT:CPR) reported a net profit margin of 6.1%, a notable drop from 11.2% the previous year, which points to a clear decline in profitability. A one-off loss of €185.7 million worsened annual results and overshadowed the company’s five-year earnings growth trend of 1.2% per year. Negative earnings growth in the last year makes direct comparisons to the longer-term average less meaningful. With market expectations now focused on forecasted annual earnings growth of 11.8%,...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Microsoft (MSFT): Annual Earnings Up 12.9%, Profit Growth Outpaces Market Narratives

Microsoft (MSFT) booked annual earnings growth of 12.9% over the last five years, with profits jumping 15.9% year over year and net profit margin reaching 35.7%, just above last year’s 35.6%. Revenue is on track to climb 12.3% per year, ahead of the US market’s 10.3% forecast, while EPS is set to rise at 14.22% annually, slightly behind the broader market’s expected pace of 15.9%. Investors will note the company’s strong and consistent profit margins, but must also weigh its above-industry...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Is Perrigo Now a Bargain After 20.6% Share Price Drop in 2025?

Ever wondered if Perrigo's share price is starting to look like a bargain, or if you might be catching a falling knife? Let's take a closer look at the forces shaping its value and what they could mean for investors hunting for opportunities. Despite a recent dip of 4% this week and being down 20.6% year-to-date, Perrigo has a history of volatility, highlighting shifting market sentiment and changing expectations for the company’s future. News around Perrigo has focused on regulatory updates...